«Synovioma». Encyclopædia Britannica Online. Consultado el 20 de mayo de 2012.
doi.org
dx.doi.org
«Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases». Cancer98 (12): 2700-7. 2003. PMID14669292. doi:10.1002/cncr.11840.
«Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study». Mod. Pathol.13 (12): 1336-46. 2000. PMID11144931. doi:10.1038/modpathol.3880247.
«Malignant peripheral nerve sheath tumors are t(X;18)-negative sarcomas. Molecular analysis of 25 cases occurring in neurofibromatosis type 1 patients, using two different RT-PCR-based methods of detection». Mod. Pathol.15 (6): 589-92. 2002. PMID12065770. doi:10.1038/modpathol.3880570.
«Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases». Cancer98 (12): 2700-7. 2003. PMID14669292. doi:10.1002/cncr.11840.
«Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases». Cancer98 (12): 2700-7. 2003. PMID14669292. doi:10.1002/cncr.11840.
«Malignant peripheral nerve sheath tumors with t(X;18). A pathologic and molecular genetic study». Mod. Pathol.13 (12): 1336-46. 2000. PMID11144931. doi:10.1038/modpathol.3880247.
«Malignant peripheral nerve sheath tumors are t(X;18)-negative sarcomas. Molecular analysis of 25 cases occurring in neurofibromatosis type 1 patients, using two different RT-PCR-based methods of detection». Mod. Pathol.15 (6): 589-92. 2002. PMID12065770. doi:10.1038/modpathol.3880570.
«Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases». Cancer98 (12): 2700-7. 2003. PMID14669292. doi:10.1002/cncr.11840.
«Impact of SS18-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients». Cancer Res.62 (1): 135-40. 2002. PMID11782370.